Thiamine: Clinical Trials

15 trials of Thiamine, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

12 completed, 2 unknown, 1 terminated. 15 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 415Completed 12, Unknown 2, Terminated 1

Follow Thiamine: new trials by email Literature Review of Thiamine trials Research Report on Thiamine

Trials (filtered) newest first · largest first

All 15 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluation of Aminobutyric Acid, Glutamic Acid, Calcium, Thiamine, Pyridoxine and Cyanocobalamin as Therapy for Vertigo
Gamma-aminobutyric acid tartarate, glutamic acid, dibasic calcium phosphate, thiamine nitrate, pyridoxine chloride and cyanocobalamin, Ginger - Vertigo
Phase 4CompletedFundação Educacional Serra dos Órgãos3342021-11-222023-05-17
PBC Induced Fatigue Treated With Thiamine
Thiamine, Placebo - Primary Biliary Cirrhosis
Phase 4UnknownHenning Grønbæk362021-05-122021-05-20
The Thiamine Administration After Cardiac Surgery Trial
Thiamine 500 MG, Placebo - Lactate Blood Increase, Thiamine Deficiency
Phase 4CompletedSarah Saxena2002020-11-202022-11-17
The Effect of SLC19A3 Inhibition on the Pharmacokinetics of Thiamine
Trimethoprim, Metformin, Vitamin B1 - Vitamin B1 Deficiency, Thiamine Deficiency
Phase 4CompletedUniversity of California, San Francisco72019-01-282025-01-03
Blessing or Curse? Combined Vitamin Therapy in Non Viral Septic Shock.
Vitamin C - Septic Shock
Phase 4CompletedUniversity of Pecs432019-01-012023-11-30
Thiamin Against Robust IBD Fatigue
Thiamine, Placebo - Fatigue
Phase 4CompletedUniversity of Aarhus402018-11-272020-10-29
Megadose of Hydroxocobalamin for the Treatment of Pernicious Anemia
Hydroxocobalamin 10,000mcg, Thiamin 100mg, Pyridoxine 50mg - Megaloblastic Anemia Nos, Pernicious Anemia
Phase 4CompletedHospital Universitario Dr. Jose E. Gonzalez132017-12-272021-03-08
The Effect of Vitamin C, Thiamine and Hydrocortisone on Clinical Course and Outcome in Patients With Severe Sepsis and Septic Shock
Vitamin C, Hydrocortisone, Thiamine - Sepsis, Septic Shock
Phase 4TerminatedUniversity Medical Centre Ljubljana52017-09-262019-02-19
Thiamin Deficiency in Obese Thai Children
Thiamine 1, Non-thiamine, Thiamine 2 - Obesity, Child
Phase 4CompletedMahidol University1242015-08-012018-10-02
A Multi-center, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy and Safety of 'Ursa Complex Soft Cap. (UDCA-004)' in Patients With Physical Fatigue.
Ursodeoxycholic acid, taurine, ginsenoside, thiamine, inositol, Placebo - Fatigue
Phase 4CompletedDaewoong Pharmaceutical Co. LTD.1662014-10-012015-04-16
Clinical Trial to Evaluate the Efficacy and Safety of 'URSA SOFT CAP. (UDCA-003)' in Fatigue Patients With Liver Dysfunction
Ursodeoxycholic acid, thiamine, riboflavin - Fatigue
Phase 4CompletedDaewoong Pharmaceutical Co. LTD.1682014-10-012016-01-22
Optimum Thiamine Intervention (OpTIn) Trial
Thiamine Hydrochloride - Wernicke-Korsakoff Syndrome
Phase 4CompletedMenzies School of Health Research3342014-09-012019-08-16
Prevention of Renal Complications of Diabetes With Thiamine
Thiamine 300mg PO once daily, placebo - Diabetic Nephropathy
Phase 4UnknownUniversity of Saskatchewan402012-11-012012-11-12
A Trial of Thiamin Supplementation in Patients With Heart Failure
Vitamin B1, Placebo - Heart Failure
Phase 4CompletedUnity Health Toronto702009-09-012018-02-27
Lactate Metabolism Study in HIV Infected Persons
cofactor supplementation (thiamine, riboflavin, L-carnitine) - HIV Infections, AIDS
Phase 4CompletedQueen's University302002-07-012016-01-13

Conditions studied

Fatigue (3)  ·  Thiamine Deficiency (3)  ·  Beriberi (2)  ·  Sepsis (2)  ·  Shock, Septic (2)  ·  Acidosis, Lactic (1)  ·  Acquired Immunodeficiency Syndrome (1)  ·  Anemia, Megaloblastic (1)  ·  Anemia, Pernicious (1)  ·  Critical Illness (1)  ·  Diabetic Nephropathies (1)  ·  Edema (1)  ·  HIV Infections (1)  ·  Heart Failure (1)  ·  Hyperlactatemia (1)

Sponsors

Daewoong Pharmaceutical Co. LTD. (2)  ·  Fundação Educacional Serra dos Órgãos (1)  ·  Henning Grønbæk (1)  ·  Hospital Universitario Dr. Jose E. Gonzalez (1)  ·  Mahidol University (1)  ·  Menzies School of Health Research (1)  ·  Queen's University (1)  ·  Sarah Saxena (1)  ·  Unity Health Toronto (1)  ·  University Medical Centre Ljubljana (1)  ·  University of Aarhus (1)  ·  University of California, San Francisco (1)  ·  University of Pecs (1)  ·  University of Saskatchewan (1)

Countries

Canada (3)  ·  Denmark (2)  ·  South Korea (2)  ·  Australia (1)  ·  Belgium (1)  ·  Brazil (1)  ·  Hungary (1)  ·  Mexico (1)  ·  Slovenia (1)  ·  Thailand (1)  ·  United States (1)

Top investigators

Andrew S Greenberg (1)  ·  Dr. Gudrun Caspar-Bell, MD (1)  ·  Kathleen M Giacomini (1)  ·  Kylie Dingwall, PhD (1)  ·  MIchael Piagnerelli, MD; PHD (1)  ·  Mary E. Keith, PhD, RD (1)  ·  Narumon Densupsoontorn, MD (1)  ·  Sebastian Stefanovic, MD (1)  ·  Wendy Wobeser, MD (1)

Results publications

PMID 10793599, PMID 14616423, PMID 15286537, PMID 17429582, PMID 17583412, PMID 19325467, PMID 20179283, PMID 20181242, PMID 20463176, PMID 20646908, PMID 22650964, PMID 23649098, PMID 23697526, PMID 23945419, PMID 24412011, PMID 25479113, PMID 26771781, PMID 26997458, PMID 27002274, PMID 28360040, PMID 28432843, PMID 29047411, PMID 30813144, PMID 31504093, PMID 33210299, PMID 34592862, PMID 3537898, PMID 37880581, PMID 38551983

NIH funding

R01DK108722 (1)